BWS
EW icon

Buck Wealth Strategies’s Edwards Lifesciences EW Stock Holding History

Buck Wealth Strategies’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.7K Buy
+240
New +$20.1K ﹤0.01% 460
2023
Q3 		– Sell
-240
Closed -$22.6K – 381
2023
Q2 		$22.6K Hold
240
– – 0.01% 108
2023
Q1 		$19.9K Buy
+240
New +$18.9K 0.01% 83

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Buck Wealth Strategies's EW Position: Q2 2026 in Review

Buck Wealth Strategies opened a new position in Edwards Lifesciences (EW) in Q2 2026: 240 shares worth $21.7K. The stake represents ﹤0.01% of the portfolio and ranks #460 among its holdings. This is a return to the name: Buck Wealth Strategies previously reported a position in EW as recently as Q2 2023.

Buck Wealth Strategies first reported a position in EW in Q1 2023 and has held it in 3 quarters since. The position peaked at $22.6K in Q2 2023. 1,338 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Buck Wealth Strategies held 240 shares of Edwards Lifesciences worth $21.7K as of Q2 2026.
  • Edwards Lifesciences was a new Buck Wealth Strategies position in Q2 2026.
  • Edwards Lifesciences made up ﹤0.01% of Buck Wealth Strategies's portfolio in Q2 2026, its #460 holding.
  • Buck Wealth Strategies first reported a position in Edwards Lifesciences in Q1 2023 and has held it in 3 quarters since.
  • Buck Wealth Strategies's Edwards Lifesciences position peaked at $22.6K in Q2 2023.
  • 1,338 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Buck Wealth Strategies's 13F filing for Q2 2026, filed 30 Jul 2026.